Global (United States, European Union and China) Contrast Injector Systems Market Research Report 2019-2025
Contrast injector systems are medical devices that use contrast media to enhance the visibility of complex body structures such as body fluids, tissues, arteries, and veins. The diagnosis is conducted with the help of many imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography.
The rise in geriatric population coupled with rapid rise in chronic diseases as well as the demand for early and minimal-invasive diagnosis are the key factors that drive the growth of the contrast injector systems market. However, the high cost of contrast injector systems and the risks associated with the use of contrast media in the injector system is projected to impede the market growth. Moreover, the increase in healthcare expenditure and the emergence of complex diseases in emerging economies are expected to create lucrative opportunities for key market players.
In 2019, the market size of Contrast Injector Systems is 620 million US$ and it will reach 1140 million US$ in 2025, growing at a CAGR of 7.9% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Contrast Injector Systems.
This report studies the global market size of Contrast Injector Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Contrast Injector Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bracco
Bayer AG
Guerbet Group
Medtron AG
Ulrich GmbH & Co. KG
GE Healthcare
Shenzhen Seacrown Electromechanical
Nemoto Kyorindo
Sino Medical- Device Technology
Vivid Imaging
Network Imaging Systems
IRadimed Corporation
Covidien
Agito Medical
Merit Medical Systems
Market Segment by Product Type
Injector Systems
Consumables
Accessories
Market Segment by Application
Diagnostics Centers
Clinics
Hospitals
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Contrast Injector Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Contrast Injector Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Contrast Injector Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
The rise in geriatric population coupled with rapid rise in chronic diseases as well as the demand for early and minimal-invasive diagnosis are the key factors that drive the growth of the contrast injector systems market. However, the high cost of contrast injector systems and the risks associated with the use of contrast media in the injector system is projected to impede the market growth. Moreover, the increase in healthcare expenditure and the emergence of complex diseases in emerging economies are expected to create lucrative opportunities for key market players.
In 2019, the market size of Contrast Injector Systems is 620 million US$ and it will reach 1140 million US$ in 2025, growing at a CAGR of 7.9% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Contrast Injector Systems.
This report studies the global market size of Contrast Injector Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Contrast Injector Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bracco
Bayer AG
Guerbet Group
Medtron AG
Ulrich GmbH & Co. KG
GE Healthcare
Shenzhen Seacrown Electromechanical
Nemoto Kyorindo
Sino Medical- Device Technology
Vivid Imaging
Network Imaging Systems
IRadimed Corporation
Covidien
Agito Medical
Merit Medical Systems
Market Segment by Product Type
Injector Systems
Consumables
Accessories
Market Segment by Application
Diagnostics Centers
Clinics
Hospitals
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Contrast Injector Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Contrast Injector Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Contrast Injector Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
